Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
TUSTIN, Calif., Sept. 18 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major assets in China, announced today its stockholders have...
TUSTIN, Calif., Aug. 20 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced the inauguration of AMDL...
TUSTIN, Calif., Aug. 19 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, today reported unaudited results and the...
TUSTIN, Calif., Aug. 14 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a U.S.-based pharmaceutical company with major operations in China, announced today it has filed a...
Company's VP of Scientific Oversight to present AMDL's Onko-Sure(TM) in vitro diagnostic cancer test to conference attendees TUSTIN, Calif., July 22 /PRNewswire-FirstCall/ -- AMDL Diagnostics...
TUSTIN, Calif., July 8 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today the launch of a new brand...
TUSTIN, Calif., June 17 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today its Chairman and CEO Mr...
TUSTIN, Calif., June 15 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today the second closing of a...
TUSTIN, Calif., May 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today unaudited results and the...
TUSTIN, Calif., May 13 /PRNewswire-FirstCall/ -- AMDL, Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today it has entered into two...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 6.45 | 8.98 | 3.66 | 8168 | 6.98067369 | DE |
| 260 | 0 | 0 | 13.54 | 14.98 | 3.66 | 23753 | 10.5049479 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
